This study showed that patients with AIH can be divided into 3 immunological phenotypes based on the B-cell directed cytokines BAFF and IL-21 levels, with differences in presentation, treatment response, and long-term outcome. The gene discussed is TNFSF13B; the disease is autoimmune hepatitis.